Georgios K. Dimitriadis

Georgios K. Dimitriadis

School Of Life Course Sciences
London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 105 publications

Diagnosis and monitoring of metabolic dysfunction-associated steatohepatitis disease: a critical review.

Diagnosis and monitoring of metabolic dysfunction-associated steatohepatitis disease: a critical review.

Journal: Critical reviews in clinical laboratory sciences

Published: August 23, 2026

A 76-Year-Old Man With Hemorrhagic Stroke, Recurrent Thromboembolic Events, and Atrial Fibrillation Under Optimal Medical Treatment: When Anticoagulants Fail.

A 76-Year-Old Man With Hemorrhagic Stroke, Recurrent Thromboembolic Events, and Atrial Fibrillation Under Optimal Medical Treatment: When Anticoagulants Fail.

Journal: Cureus

Published: July 12, 2026

Glycemia-based predictors of T2D development in adults with obesity and prediabetes: SURMOUNT-1 post hoc analysis.

Glycemia-based predictors of T2D development in adults with obesity and prediabetes: SURMOUNT-1 post hoc analysis.

Journal: Journal of the Endocrine Society

Published: April 20, 2026

Predicted 10-Year Cardiovascular Disease Risk Reduction with Tirzepatide Use Over Three Years for Primary Prevention of Cardiovascular Disease in Obesity.

Predicted 10-Year Cardiovascular Disease Risk Reduction with Tirzepatide Use Over Three Years for Primary Prevention of Cardiovascular Disease in Obesity.

Journal: European journal of preventive cardiology

Published: March 23, 2026

Association of tirzepatide with changes in OSA-related measures based on baseline characteristics - post hoc analyses of SURMOUNT-OSA.

Association of tirzepatide with changes in OSA-related measures based on baseline characteristics - post hoc analyses of SURMOUNT-OSA.

Journal: Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine

Published: February 20, 2026

Reversion to normoglycemia with tirzepatide vs semaglutide in participants with obesity and prediabetes: a post hoc analysis of SURMOUNT-5.

Reversion to normoglycemia with tirzepatide vs semaglutide in participants with obesity and prediabetes: a post hoc analysis of SURMOUNT-5.

Journal: Journal of endocrinological investigation

Published: January 24, 2026

Shifts in waist-to-height ratio categories within tirzepatide groups: a post-hoc analysis of SURMOUNT-1.

Shifts in waist-to-height ratio categories within tirzepatide groups: a post-hoc analysis of SURMOUNT-1.

Journal: Journal of endocrinological investigation

Published: January 19, 2026

Association of Tirzepatide With Kidney Parameters in Participants With Obesity and Prediabetes From SURMOUNT-1 Over 176 Weeks.

Association of Tirzepatide With Kidney Parameters in Participants With Obesity and Prediabetes From SURMOUNT-1 Over 176 Weeks.

Journal: Diabetes, obesity & metabolism

Published: December 08, 2025

Nutritional status with tirzepatide in obesity: A post hoc analysis of the SURMOUNT-1-4 randomized clinical trials.

Nutritional status with tirzepatide in obesity: A post hoc analysis of the SURMOUNT-1-4 randomized clinical trials.

Journal: Obesity pillars

Published: November 22, 2025

Indirect Comparative Efficacy and Safety of Tirzepatide Versus Oral Semaglutide for the Treatment of Overweight and Obesity.

Indirect Comparative Efficacy and Safety of Tirzepatide Versus Oral Semaglutide for the Treatment of Overweight and Obesity.

Journal: Diabetes, obesity & metabolism

Published: November 05, 2025

A treat-to-target approach for obesity management: A post hoc analysis of the SURMOUNT-5 trial.

A treat-to-target approach for obesity management: A post hoc analysis of the SURMOUNT-5 trial.

Journal: Diabetes, obesity & metabolism

Published: October 31, 2025

Comparison of Clinical Efficacy and Safety of Tirzepatide, Liraglutide and Semaglutide in Patients with Obesity and Without T2D: A Bayesian Network Meta-Analysis of Randomised Controlled Trials.

Comparison of Clinical Efficacy and Safety of Tirzepatide, Liraglutide and Semaglutide in Patients with Obesity and Without T2D: A Bayesian Network Meta-Analysis of Randomised Controlled Trials.

Journal: Advances in therapy

Published: October 23, 2025

Showing 1-12 of 105

Last Updated: 09/26/2026